Free Trial
NASDAQ:TLX

Telix Pharmaceuticals (TLX) Stock Price, News & Analysis

Telix Pharmaceuticals logo
$16.65 -0.09 (-0.54%)
Closing price 06/17/2025 03:57 PM Eastern
Extended Trading
$16.58 -0.07 (-0.42%)
As of 06/17/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Telix Pharmaceuticals Stock (NASDAQ:TLX)

Key Stats

Today's Range
$16.21
$17.17
50-Day Range
$15.91
$19.22
52-Week Range
$13.61
$30.36
Volume
4,212 shs
Average Volume
25,847 shs
Market Capitalization
$5.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
Consensus Rating
Buy

Company Overview

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Receive TLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TLX Stock News Headlines

When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
William Blair Has Bullish Estimate for TLX FY2025 Earnings
See More Headlines

TLX Stock Analysis - Frequently Asked Questions

Telix Pharmaceuticals' stock was trading at $15.40 at the start of the year. Since then, TLX shares have increased by 8.1% and is now trading at $16.65.
View the best growth stocks for 2025 here
.

Telix Pharmaceuticals (TLX) raised $202 million in an IPO on Friday, June 14th 2024. The company issued 17,000,000 shares at $11.87 per share.

Telix Pharmaceuticals' top institutional shareholders include ABC Arbitrage SA (0.01%) and Private Advisor Group LLC.

Shares of TLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLX
Previous Symbol
NASDAQ:TLX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.00
High Stock Price Target
$22.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+32.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$783.21 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$5.63 billion
Optionable
N/A
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:TLX) was last updated on 6/18/2025 by MarketBeat.com Staff
From Our Partners